BCL6 and neoplasm: Because of the low numbers of Th1 and Tfh positive cells in tumor tissue, these immunostainings were validated by comparing two different mAb clones for each transcription factor (T-bet and BCL6), and similar results were obtained (Supplementary Figures 5, 6).